2474亿元!中国创新药“销冠”落定

赛柏蓝
Oct 19

编者按:本文来自药智网,作者小铃铛;赛柏蓝授权转载,编辑晓琳2016年至2025年上半年,中国创新药国内公立医疗机构销售额排名第一的企业为阿斯利康,累计实现销售额2474亿元,也是榜单中唯一突破2000亿元大关的药企。01市场霸主成绩单在2016年至2025年上半年期间,中国公立医疗机构终端的创新药销售额TOP10企业被跨国药企包揽,拜耳、辉瑞、赛诺菲、罗氏、诺华等行业巨头均在列,其中前七名销售额...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10